Koninklijke Philips (NYSE:PHG – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Thursday.
Separately, Jefferies Financial Group upgraded shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday, October 29th. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, Koninklijke Philips presently has a consensus rating of “Hold”.
Read Our Latest Analysis on Koninklijke Philips
Koninklijke Philips Stock Performance
Hedge Funds Weigh In On Koninklijke Philips
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in shares of Koninklijke Philips in the 1st quarter worth about $40,000. Envestnet Portfolio Solutions Inc. boosted its position in Koninklijke Philips by 9.8% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 23,475 shares of the technology company’s stock worth $469,000 after purchasing an additional 2,102 shares during the last quarter. Sei Investments Co. grew its stake in shares of Koninklijke Philips by 12.0% during the 1st quarter. Sei Investments Co. now owns 360,176 shares of the technology company’s stock valued at $7,204,000 after purchasing an additional 38,532 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Koninklijke Philips during the 1st quarter valued at about $91,000. Finally, US Bancorp DE raised its position in Koninklijke Philips by 8.0% in the first quarter. US Bancorp DE now owns 74,673 shares of the technology company’s stock worth $1,493,000 after acquiring an additional 5,544 shares during the period. Hedge funds and other institutional investors own 13.67% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
- Five stocks we like better than Koninklijke Philips
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- The 3 Best Retail Stocks to Shop for in August
- Top-Performing Non-Leveraged ETFs This Year
- Upcoming IPO Stock Lockup Period, Explained
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.